Stocksigma LogoStocksigma Logo

CRISIL Reaffirms and Withdraws Key Debt Ratings for Mankind Pharma

On 29th Oct'26, CRISIL Ratings reaffirmed its 'CRISIL AA+/Stable' rating on Mankind Pharma Limited’s Non-Convertible Debentures (NCDs) worth ₹400 crore and

CRISIL Reaffirms and Withdraws Key Debt Ratings for Mankind Pharma

Mankind Pharma Ltd · Others (Uncategorized) · 30 Oct 2026, 1:56 am

CRISIL Reaffirms and Withdraws Key Debt Ratings for Mankind Pharma On 29th Oct'26, CRISIL Ratings reaffirmed its 'CRISIL AA+/Stable' rating on Mankind Pharma Limited’s Non-Convertible Debentures (NCDs) worth ₹400 crore and ₹2,100 crore. Simultaneously, the agency withdrew its 'CRISIL AA+/Stable' rating on NCDs amounting to ₹2,500 crore and its 'CRISIL A1+' rating on Commercial Paper totaling ₹1,500 crore.

Original exchange filing (PDF)

More announcements from Mankind Pharma Ltd

All Mankind Pharma Ltd announcements